Urgent

De-escalation and physical restraint (safe practice)

De-escalation · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A structured, graded response to the agitated or aggressive patient prioritising verbal de-escalation and environmental measures, reserving physical restraint and rapid tranquillisation for when these fail. Prolonged prone restraint is dangerous and should be avoided; restraint is a bridge to assessment, not a treatment.

Red flags

  • Any sign of airway or breathing compromise during restraint
  • Prolonged or prone restraint, or restraint of a pregnant patient
  • Falling SpO2, hypotension or bradycardia after sedation
  • Cyanosis, reduced consciousness or sudden collapse
  • Restraining a patient with undiagnosed medical cause

Assessment

Differential diagnosis

  • Organic delirium (hypoxia, sepsis, hypoglycaemia, head injury, post-ictal)
  • Acute intoxication or withdrawal (alcohol, stimulants, GHB)
  • Acute psychosis or mania
  • Hypoglycaemia or metabolic cause
  • Personality disorder crisis or situational distress

Investigations

  • Capillary glucose and continuous observations once safe
  • Pulse oximetry and capnography during/after any sedation
  • ECG before parenteral antipsychotic where feasible
  • Bloods and toxicology once controlled
  • CT head if trauma or focal signs after settling

Management

  • Ensure staff safety: adequate numbers, remove ligatures/weapons, clear exit routes, call security
  • Attempt verbal de-escalation: calm tone, personal space, acknowledge concerns, offer choices and oral medication
  • Reduce environmental triggers (noise, crowding, lights); consider a quiet room
  • If de-escalation fails and risk is high, use coordinated physical restraint by trained staff with a team leader controlling the head/airway
  • Avoid prone restraint and never obstruct the chest/neck; limit restraint duration
  • Administer rapid tranquillisation if required, with continuous monitoring of airway, SpO2, pulse and level of consciousness
  • Review legal framework (MHA / MCA / common law) and document rationale
  • Debrief patient and staff afterwards and arrange review

Drugs & doses

Lorazepam — 1-2 mg PO/IM, repeat after 30-45 min; max 4 mg/24h caution
Haloperidol — 5 mg IM (2.5 mg elderly) + lorazepam; ECG first; max 12 mg/24h
Promethazine — 50 mg IM (benzodiazepine-tolerant patients)
Flumazenil — 200 mcg IV over 15 s (benzodiazepine reversal kit must be available during restraint)
Procyclidine — 5-10 mg IM/IV for acute dystonia from antipsychotic

Disposition

Once safely controlled, reassess for organic cause and refer for psychiatric assessment under MHA where indicated; patients requiring ongoing restraint/sedation need a monitored bed and senior review.

Complications & pitfalls

  • Positional asphyxia from prone restraint
  • Over-sedation, respiratory depression and aspiration
  • Rhabdomyolysis from prolonged struggle (sudden death risk)
  • QT prolongation and arrhythmia from antipsychotics
  • Physical injury and psychological trauma to patient and staff

Exam pearls

  • Prone restraint kills — keep the patient supine or on their side and protect the airway
  • Have flumazenil and resuscitation equipment immediately available during rapid tranquillisation
  • Oral medication is preferred if the patient will accept it; offer it before IM
  • Continuous physical monitoring post-sedation is mandatory (NEWS2, SpO2, capnography)
  • Restraint is a last resort and legally must be proportionate and the least restrictive option

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.